Number of COVID-19 vaccine doses produced by Sinovac 2021-2022
the domestic market, a large number of doses were also exported, mainly to lower and middle-income countries. Thanks to the strong demand for its COVID-19 vaccines worldwide, Sinovac reported strong financial performance in 2021, with its annual revenue increased almost 3,700 percent from the previous year.
By the end of January, the Chinese vaccine firm Sinovac had produced almost 2.5 billion COVID-19 vaccine doses, representing around half of all COVID-19 vaccine doses manufactured nationwide. Although most of Sinovac's CoronaVac vaccines are intended for